Amarantus Bioscience Holdings Inc (AMBS)

[ronpopeil]

AMGN co-founder on board!?! Nice

"The identification of an orphan indication for MANF is a key milestone towards the initial commercialization for MANF," said Dr. Joseph Rubinfeld, Amgen co-founder and current member of the Company's Board of Advisors. "The delivery of MANF directly to the eye in this indication will be local, potentially significantly reducing timelines to get this into the marketplace versus systemic applications. We are continuing to look at MANF in other orphan indications and expect to have data in other areas in the coming weeks."